CHRS
#3570
Coherus Oncology, Inc. - Common Stock
1.3 9 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.11%
Variación mensual
-4.79%
Variación en los últimos 6 meses
-17.26%
Cambio anual
-13.66%
Cierres anteriores
1.4 2
Open
1.3 9
Mínimo
1.3 9
Máximo
1.4 0
Volumen
50
Financials
- Market Capitalization 214.76 M
- Employee 144
- Founded 2010
- CEO Dennis Lanfear
- Website www.coherus.com
- Headquarter Delaware, United States
- FIGI BBG0063N8V69
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
0.99
Relación precio/flujo de caja
3.94
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3563 |  RNA Atrium Therapeutics, Inc. - Common Stock | 13.44 USD | +1.82% | +4.75% | +15.76% | -80.89% | 229.90 M USD | ||
| 3566 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 3.10 USD | -1.90% | +16.54% | +41.55% | +103.95% | 224.18 M USD | ||
| 3572 |  PEPG PepGen Inc. - Common Stock | 3.18 USD | +1.27% | +6.35% | +63.08% | +140.91% | 220.25 M USD | ||
| 3573 |  BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.36 USD | -0.23% | +10.38% | +11.79% | -38.59% | 220.42 M USD |